Three-dimensional evaluation of subclinical extension of extramammary Paget disease: visualization of the histological border and its comparison to the clinical border
- PMID: 28028810
- DOI: 10.1111/bjd.15282
Three-dimensional evaluation of subclinical extension of extramammary Paget disease: visualization of the histological border and its comparison to the clinical border
Abstract
Background: In extramammary Paget disease (EMPD), Paget cells are sometimes detected outside the clinical border (subclinical extension). However, the spreading pattern of Paget cells in subclinical extension remains unclear. In addition, the macroscopic appearances of lesions accompanied by subclinical extension are totally unknown.
Objectives: To characterize the spreading pattern of Paget cells as well as the macroscopic appearance of lesions of EMPD with subclinical extension.
Methods: Nineteen patients with primary anogenital EMPD underwent mapping biopsies and excisional surgeries; biopsy samples were then taken at the periphery of well-demarcated lesions. Samples were transparentized and subjected to whole-mount immunostaining with anticytokeratin 7 antibody to label Paget cells. The histological border was evaluated in three dimensions by two-photon microscopy. The shape and location of the histological border were compared with those of the clinical border.
Results: In 21 samples taken at the lesion where subclinical extension was not shown by mapping biopsy, the shape and location of the histological border were almost identical to those of the clinical border. However, two samples exhibited small foci of Paget cells outside the clinical border, showing subclinically extended satellite lesions. In the two samples taken at the lesions where subclinical extension was shown by mapping biopsy, a continuous arrangement of Paget cells extending beyond the clinical border was identified. Subclinically extended Paget cells were detected solely outside hypopigmented patches with erythema.
Conclusions: In EMPD, at least two patterns of subclinical extension exist: continuous and satellite lesions. Subclinical extension might exist preferentially outside hypopigmented patches with erythema.
© 2016 British Association of Dermatologists.
Comment in
-
New technology discloses the tumour margin of extramammary Paget disease?Br J Dermatol. 2017 Jul;177(1):18-19. doi: 10.1111/bjd.15612. Br J Dermatol. 2017. PMID: 28731239 No abstract available.
Similar articles
-
Evaluation of mapping biopsies for extramammary Paget disease: A retrospective study.J Am Acad Dermatol. 2018 Jun;78(6):1171-1177.e4. doi: 10.1016/j.jaad.2017.12.040. Epub 2017 Dec 23. J Am Acad Dermatol. 2018. PMID: 29277730
-
Axillary Paget disease with a visible satellite: a case report and literature review.Diagn Pathol. 2021 Aug 1;16(1):69. doi: 10.1186/s13000-021-01131-1. Diagn Pathol. 2021. PMID: 34334143 Free PMC article. Review.
-
In vivo reflectance confocal microscopy of extramammary Paget disease: diagnostic evaluation and surgical management.J Am Acad Dermatol. 2012 Feb;66(2):e47-53. doi: 10.1016/j.jaad.2010.09.722. Epub 2011 May 26. J Am Acad Dermatol. 2012. PMID: 21620517
-
Extramammary Paget's disease: extended subclinical growth detected using three-dimensional histology in routine paraffin procedure and course of the disease.Dermatol Surg. 2011 Oct;37(10):1417-26. doi: 10.1111/j.1524-4725.2011.02091.x. Epub 2011 Jul 18. Dermatol Surg. 2011. PMID: 21767327
-
The diagnosis and management of extramammary Paget's disease.Expert Rev Anticancer Ther. 2018 Jun;18(6):543-553. doi: 10.1080/14737140.2018.1457955. Epub 2018 Mar 27. Expert Rev Anticancer Ther. 2018. PMID: 29575944 Review.
Cited by
-
Sensitive label-free imaging of brain samples using FxClear-based tissue clearing technique.iScience. 2021 Mar 5;24(4):102267. doi: 10.1016/j.isci.2021.102267. eCollection 2021 Apr 23. iScience. 2021. PMID: 33817573 Free PMC article.
-
Current Management and Treatment of Extramammary Paget's Disease.Curr Treat Options Oncol. 2022 Jun;23(6):818-830. doi: 10.1007/s11864-021-00923-3. Epub 2022 Apr 4. Curr Treat Options Oncol. 2022. PMID: 35377101 Review.
-
KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.Hum Cell. 2023 Sep;36(5):1813-1829. doi: 10.1007/s13577-023-00951-1. Epub 2023 Jul 11. Hum Cell. 2023. PMID: 37432591
-
FOXM1: a new therapeutic target of extramammary Paget disease.Sci Rep. 2024 Feb 19;14(1):4048. doi: 10.1038/s41598-024-54773-8. Sci Rep. 2024. PMID: 38374400 Free PMC article.
-
Skin Imaging Using Ultrasound Imaging, Optical Coherence Tomography, Confocal Microscopy, and Two-Photon Microscopy in Cutaneous Oncology.Front Med (Lausanne). 2019 Nov 22;6:274. doi: 10.3389/fmed.2019.00274. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31824956 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical